Mingzhao Xing

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

Mingzhao Xing, William H. Westra, Ralph P. Tufano et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 994 citations · Full text

Medicine, Oncology, Metastasis +15

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson et al. · JAMA · 2013 · 926 citations

Medicine, Molecular Medicine, Oncology +15

BRAF Mutation in Papillary Thyroid Carcinoma

Yoram Cohen, Mingzhao Xing, Elizabeth Mambo et al. · JNCI Journal of the National Cancer Institute · 2003 · 924 citations · Full text

Medicine, Genetics, Oncology +14

<i>BRAF</i> V600E and <i>TERT</i> Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

Mingzhao Xing, Rengyun Liu, Xiaoli Liu et al. · Journal of Clinical Oncology · 2014 · 715 citations · Full text

Medicine, Genetics, Oncology +15

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

Xiaoli Liu, Justin A. Bishop, Sara I. Pai et al. · Endocrine Related Cancer · 2013 · 607 citations · Full text

Medicine, Genetics, Molecular Genetics +16